Related Experiment Video
Updated: Apr 5, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Presentation of childhood cancers to a paediatric shared care unit
Jeremy Roskin1, James Diviney2, Vasanta Nanduri1
1Department of Paediatrics, Watford General Hospital, Watford, UK.
Insights
Most children with cancer present via emergency services, not the 2-week pathway. Pediatric cancer diagnosis routes vary by tumor type, with acute presentations being most common.
Area of Science:
- Pediatric Oncology
- Cancer Diagnosis Pathways
- Health Services Research
Background:
- Understanding patient pathways is crucial for timely cancer diagnosis in children.
- Shared care oncology units play a role in managing pediatric cancer cases.
- Existing referral pathways may not be optimal for pediatric oncology.
Purpose of the Study:
- To delineate the diagnostic pathways for children with cancer presenting to a shared care oncology unit.
- To compare presentation and diagnosis timelines across different pediatric cancer types.
- To evaluate the effectiveness of the 2-week pathway in pediatric oncology.
Main Methods:
- A retrospective cohort study analyzed 93 children aged 0-15 diagnosed with cancer between 2004-2014.
- Patient pathways from initial symptoms to diagnosis were mapped.
- Time to presentation (TTP) and time to diagnosis (TTD) were calculated.
Main Results:
- Only 2.1% of cases utilized the 2-week pathway; most (67%) presented acutely via general practitioner referral or emergency department.
- Leukemia predominantly presented acutely via GPs, while solid tumors were more often self-referred to the emergency department.
- Wilms' tumor had the shortest median TTP (7 days) and TTD (16 days), whereas lymphoma had the longest TTD (120 days).
Conclusions:
- The majority of pediatric cancer diagnoses occur through acute services, with significant variation based on tumor type.
- The 2-week pathway appears infrequently used and potentially less relevant for pediatric cancer referrals.
- Optimizing referral pathways for pediatric oncology requires further investigation into acute presentation patterns.
Objective:
To describe the pathways by which children with cancer present to a shared care oncology unit.
Design:
A population-based retrospective cohort study of children diagnosed with cancer between the years 2004 and 2014.
Setting:
District General Hospital with a level 2 Paediatric Oncology Shared Care Unit.
Patients:
93 children aged 0-15 years .
Outcome Measures:
Time to presentation (TTP) was defined as time from initial symptoms to time seen by secondary paediatrics. Time to diagnosis (TTD) was defined as time from initial symptoms to diagnosis at a Principal Treatment Centre. Patient pathways to diagnosis were mapped and routes for different cancers were compared.
Results:
Only 2/93 cases (2.1%) in 10 years were referred via the 2-week pathway. Most presentations were acute via immediate general practitioner (GP) referral or self-referral to the emergency department 62/93 (67%). Leukaemia presented acutely and via the GP more often than via self-presentation to the emergency department 21/28 (75% vs 25%), while solid tumours were self-referred to the emergency department 21/34 (62% vs 38%) more often than via the GP. TTP and TTD were calculated for 87 patients. Wilms' tumour demonstrated the shortest median TTP of 7 days and TTD of 16 days. Lymphoma had the longest TTD, with TTP 107 days and TTD 120 days. Pathways to diagnosis via other specialties were longer.
Conclusion:
The majority of children diagnosed with cancer present via acute services, with the route varying between tumour types. Only two cases in 10 years were referred via the 2-week pathway, thus challenging its relevance in the paediatric population.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Treatment Resistant Cancers
Treatment Resistent Cancers
The Retinoblastoma Gene
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

